The Serum Institute has revealed that it has received the purchase order from Indian Govt. to procure 11 million doses of the COVID-19 vaccine and it will also be manufacturing Oxford-AstraZeneca’s, Covishield in India which will be available for Rs. 200 per vial.
The distribution process will begin from Jan 11 and the handling/distribution of Covishield from Serum’s Pune based facility will be done at Mumbai airport while Pune airport will handle 40-45% of the order.